ALXN1920

· Alexion Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ALXN1920, covering 2024-11-27 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN) [Phase 2]